New Scientist reports that songbirds have an extra chromosome within their germline, but not other, cells.
Using genome sequence data for 429 accessions, an international team tracked chickpea's origin and spread, while identifying markers for important traits.
Australia's ABC News looks into what's next after the country decides not to regulate some gene editing of plants and animals.
An Australian twin study finds that environmental factors rather than genetic ones may sway early cavity development, Reuters reports.
In PLOS this week: HLA-region changes linked to lupus risk among East Asians, epigenome-wide association study of maternal circadian rhythm, and more.
The project plans to sequence 20,000 genomes in 2019, 50,000 by the end of 2020, and a total of 100,000 by the end of 2021 using Oxford Nanopore's PromethIon platform.
Illumina said that the DTC market is in "transition" from ancestry and genealogy to one driven by demand for health information.
The South China Morning Post reports eight genetic testing firms in Hong Kong are under scrutiny for potentially misleading consumers.
In Science this week: platform to diagnose genetic disease in children, lung disease-causing genetic mutation corrected in mice, and more.
Japanese software giant NEC invests in AI-centric software company BostonGene to advance immuno-oncology and other targeted cancer treatments.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.